Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Andrae

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumoniaPaul S Covington, J Michael Davenport, David A Andrae, et al.
Ophthalmology and Therapy|October 13, 2021
Development of the Presbyopia Impact and Coping QuestionnaireNathan Johnson, Elaheh Shirneshan, Cheryl D Coon, et al.
Journal of Patient-Reported Outcomes|December 2, 2021
Development of the Near Vision Presbyopia Task-based Questionnaire for use in evaluating the impact of presbyopiaElaheh Shirneshan, Cheryl D Coon, Nathan Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2020
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis QuestionnaireJeffrey J Swigris, David A Andrae, Tara Churney, et al.
European Urology Focus|January 16, 2021
Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB OutcomesChristopher Chapple, Con Kelleher, Emad Siddiqui, et al.
Journal of Patient-Reported Outcomes|November 9, 2023
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trialDavid A Andrae, Rachael F Grace, Adrian Jewett, et al.
The New England Journal of Medicine|January 21, 2016
Eluxadoline for Irritable Bowel Syndrome with DiarrheaAnthony J Lembo, Brian E Lacy, Marc J Zuckerman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumoniaPaul S Covington, J Michael Davenport, David A Andrae, et al.
Ophthalmology and Therapy|October 13, 2021
Development of the Presbyopia Impact and Coping QuestionnaireNathan Johnson, Elaheh Shirneshan, Cheryl D Coon, et al.
Journal of Patient-Reported Outcomes|December 2, 2021
Development of the Near Vision Presbyopia Task-based Questionnaire for use in evaluating the impact of presbyopiaElaheh Shirneshan, Cheryl D Coon, Nathan Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2020
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis QuestionnaireJeffrey J Swigris, David A Andrae, Tara Churney, et al.
European Urology Focus|January 16, 2021
Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB OutcomesChristopher Chapple, Con Kelleher, Emad Siddiqui, et al.
Journal of Patient-Reported Outcomes|November 9, 2023
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trialDavid A Andrae, Rachael F Grace, Adrian Jewett, et al.
The New England Journal of Medicine|January 21, 2016
Eluxadoline for Irritable Bowel Syndrome with DiarrheaAnthony J Lembo, Brian E Lacy, Marc J Zuckerman, et al.
Pageof 2